GI Dynamics To Present Data From Clinical Weight Loss Study Of EndoBarrier? Gastrointestinal Liner In Morbidly Obese Patients
Oct 1st 2008Drug InformationObesity / Weight Loss / Fitness
GI Dynamics, a medical device company pioneering the development of new approaches to treating metabolic disorders, today announced that new data regarding EndoBarrier?, its novel, noninvasive device currently in clinical trials to treat obesity and type 2 diabetes, will be presented at the International Federation for Surgery of Obesity and Metabolic Disorders (IFSO) 13th World Congress in Buenos Aires, Argentina.
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
